Collegamenti ai contenuti della pagina:
il contenuto della pagina -
il menu di navigazione -

Contenuto della pagina

Nanomedicine for Drug Delivery (NANOMED)


UNIPV structure involved:
Department of Drug Sciences

UNIPV Team: p
rof. Carla Caramella, prof. Bice Conti, prof. Marco Terreni

Project Duration:
1 preparatory year + 3 consecutive intakes

Start Date:
01 Sep 2016                                          End Date: 31 Aug 2021

Paris Descartes University - France

Full Partners: 
University of Patras – Greece, University of Pavia – Italy, University of Angers – France

Academic associate partners: 
Galien Institute, School of Pharmacy, University of Paris South (France), University of Bourgogne (France), University of Nantes (France), Interuniversity Consortium TEFARCO Innova (Italy), University of Roma Tor Vergata (Italy), University of Athens (Greece)
Foundation of Research and Technology Hellas (FORTH, Greece), University of Liège (Belgium), University of Navarra (Spain), University of Granada (Spain), University of Columbia, USA

Non-academic associate partners:
 Foundation for Research and Technology Hellas, Institute of Chemical Engineering Sciences, (FORTH / ICE-HT) (Greece), CARLINA technologies, GATTEFOSSE, GUERBET, SANOFI, DEMO PHARMACEUTICALS, ELPEN, VERISFIELD, Proxagen

€ 1.906.000,00


The Nanomedicine for Drug Delivery NANOMED EMJMD is a 22-months-long curriculum offering a high quality and multidisciplinary education in the emerging field of Nanomedicine. 

The design of nanomedicines for drug delivery requires combining knowledge from Pharmacy, Biology, Chemistry, Medicine, Physics and Engineering which makes the NANOMED EMJMD a highly multidisciplinary Master’s degree. The frame of the EMJMD has thus been elaborated in order to be able to welcome students from different backgrounds who would show an interest in the field of Nanomedicine.
NANOMED  aims at filing the gap between basic training in Drug Delivery currently provided by most Schools of Pharmacy at Master level and advanced knowledge in Nanomedicine required for post-graduate young scientists. Participating to the NANOMED EMJMD will thus be a great opportunity for future graduates to tackle Nanomedicine through multi-disciplinary perspectives and to be able to integrate the progress made in the field of Nanotechnology on the development of Advanced Particulate Drug Delivery Systems.

NANOMED provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final traineeship (Semester 4, 30 ECTS).